Guiqiang Wang
Peking University First Hospital
10
9
1
N/A
0
5
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (10)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Yan Wang
Peking University First Hospital
Shared therapeutic areas:
Worked with same sponsors:
Eric Bellissant, MD, PhD
Rennes University Hospital
Shared therapeutic areas:
Liang Peng, Doctor
Third Affiliated Hospital, Sun Yat-Sen University
Shared therapeutic areas:
Xiaolong Qi, MD
LanZhou University
Shared therapeutic areas:
Worked with same sponsors:
Ed Doo, MD
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Shared therapeutic areas:
Hamid Gourabi, PhD
head of Royan Institute
Shared therapeutic areas:
Jeong Min Lee, MD
Seoul National University Hospital
Shared therapeutic areas:
Sabine Hazan, MD
ProgenaBiome
Shared therapeutic areas:
Yimin Mao
RenJi Hospital
Shared therapeutic areas:
Mohamed mamdouh Elsayed, MD
Lecturer
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (10)
Showing 10 of 10 trials
Evaluate the Safety and Efficacy of STSG-0002 Injection in Patients With Chronic Hepatitis B
To Evaluate the Safety and Efficacy of STSG-0002 Injection in Patients With Chronic Hepatitis B
Corona Virus Disease 2019 Patients Whose Nucleic Acids Changed From Negative to Positive
Efficacy and Safety of Anluohuaxian in the Treatment of Rehabilitation Patients With Corona Virus Disease 2019
Favipiravir Combined With Tocilizumab in the Treatment of Corona Virus Disease 2019
A Study in Reversing Hepatic Fibrosis or Cirrhosis Related to Hepatitis B Virus and Finding Biomarkers
Prospective Stuy in Evaluating Hepatic Fibrosis Related to Hepatitis B Virus Using Non-invasive Parameters
Portal Vein Thrombosis in Cirrhosis: Incidence, Outcomes and Anticoagulation
A Study of Sequential Therapy With AHB-137 Injection Followed by TVAX-008 Injection in Participants Living With Chronic Hepatitis B (CHB)
A Study of Sequential Therapy With AHB-137 Injection Followed by TVAX-008 Injection in Participants Living With Chronic Hepatitis B (CHB)
All 10 trials loaded